# Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome

> **NCT03291197** · PHASE4 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 5 (actual)

## Conditions studied

- Shoulder Hand Syndrome
- Complex Regional Pain Syndromes

## Interventions

- **DRUG:** Suprascapular and median nerve blocks

## Key facts

- **NCT ID:** NCT03291197
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-15
- **Primary completion:** 2018-10-14
- **Final completion:** 2018-10-14
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03291197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03291197, "Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03291197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*